专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20080306163A1 AGENT FOR TREATMENT OF ALLERGIC EYE DISEASE 失效
标题翻译：用于治疗过敏性眼病的药剂
公开(公告)号：US20080306163A1
公开(公告)日：2008-12-11
申请号：US12189040
申请日：2008-08-08
申请人： Shinji Ina , Akane Takahama
发明人： Shinji Ina , Akane Takahama
IPC分类号： A61K31/136 , A61P37/08
CPC分类号： A61K31/122
摘要： An agent for the treatment of allergic eye disease containing a 3-anilino-2-cycloalkenone derivative having the formula (I): wherein R1 is an unsubstituted or substituted C1 to C8 alkyl group provided that an unsubstituted methyl group is excluded, a C3 to C7 cycloalkyl group, a C6 to C10 bicycloalkyl group or an indanyl group, etc., R2 is a C1 to C4 alkyl group, R3 is a hydrogen atom, a C1 to C5 alkyl group, a C3 to C7 cycloalkyl group, etc., R4 is a hydrogen atom, an unsubstituted or substituted C1 to C5 alkyl group, a halogen atom, etc., R5, R6, R7 and R8 are independently a hydrogen atom, a C1 to C5 alkyl group, etc., X is —(CR11R12)n— or NR13—, wherein n is 0 to 2, R11, R12 and R13 are independently a hydrogen atom, a C1 to C5 alkyl group, etc.
摘要翻译：用于治疗含有具有式（I）的3-苯胺基-2-环烯酮酮衍生物的过敏性眼病的药剂：其中R1是未取代或取代的C1至C8烷基，条件是排除未取代的甲基，C3至 C7环烷基，C6〜C10二环烷基或茚满基等，R2为C1〜C4烷基，R3为氢原子，C1〜C5烷基，C3〜C7环烷基等， R4是氢原子，未取代或取代的C1至C5烷基，卤素原子等，R5，R6，R7和R8独立地是氢原子，C1-C5烷基等，X是 - （ CR 11 R 12）n或NR 13 - ，其中n为0至2，R 11，R 12和R 13独立地为氢原子，C 1至C 5烷基等

2. 发明授权

US06235736B1 3-anilino-2-cycloalkenone derivatives 失效
标题翻译： 3-苯胺基-2-环烯酮酮衍生物
公开(公告)号：US06235736B1
公开(公告)日：2001-05-22
申请号：US09446822
申请日：2000-03-20
申请人： Shinji Ina , Kenjirou Yamana , Kyoji Noda , Akane Takahama , Toshihiko Akiyama
发明人： Shinji Ina , Kenjirou Yamana , Kyoji Noda , Akane Takahama , Toshihiko Akiyama
IPC分类号： A61K31136
CPC分类号： C07D295/116 , C07C225/20 , C07C225/22 , C07C2601/02 , C07C2601/08 , C07C2601/16 , C07C2602/08 , C07C2602/42 , C07D211/86 , C07D213/38 , C07D215/12 , C07D307/20
摘要： A 3-anilino-2-cycloalkenone derivative of the formula (I): wherein, R1 represents a C1 to C8 alkyl group, which may have a substituent, except for a methyl group, a C3 to C7 cycloalkyl group, a 3-tetrahydrofuryl group, an 2-indanyl group, etc., R2 represents a C1 to C4 alkyl group, R3 represents a hydrogen atom, a C3 to C7 alkyl group, which may have a substituent, a C3 to C7 cycloalkyl group, etc., R4 represents a hydrogen atom, a C1 to C5 alkyl group, which may have a substituent, a halogen atom, etc., R5, R6, R7, and R8 independently represent a hydrogen atom, a C1 to C5 alkyl group, which may have a substituent, etc., X represents —(CR11R12)n—, wherein n is 0 to 2, R11 and R12 independently represent a hydrogen atom, a C1 to C5 alkyl group, which may have a substituent, etc. or —NR13— wherein R13 represents a hydrogen atom or a C1 to C5 alkyl group, which may have a substituent, and its optical isomers or their pharmaceutically acceptable salts or their hydrates or solvates.
摘要翻译：式（I）的3-苯胺基-2-环烯酮酮衍生物：其中，R 1表示可以具有取代基的C1〜C8烷基，除了甲基，C3〜C7环烷基，3-四氢呋喃基基，1,2-二氢化茚基等，R2表示C1〜C4烷基，R3表示氢原子，可具有取代基的C3〜C7烷基，C3〜C7环烷基等，R4 表示氢原子，可具有取代基的C1〜C5烷基，卤素原子等，R5，R6，R7和R8分别表示氢原子，C1〜C5烷基，可以具有取代基等，X表示 - （CR 11 R 12）n - ，其中n为0至2，R 11和R 12独立地表示氢原子，可具有取代基的C1至C5烷基等，或-NR13-，其中 R13表示可以具有取代基的氢原子或C1〜C5烷基，及其光学异构体或其药学上可接受的盐或其水合物或溶剂化物。

3. 发明授权

US06943195B2 Cycloalkenone derivative 失效
标题翻译：环烯酮酮衍生物
公开(公告)号：US06943195B2
公开(公告)日：2005-09-13
申请号：US10481060
申请日：2002-06-27
申请人： Toshihiko Akiyama , Shinji Ina , Akane Takahama
发明人： Toshihiko Akiyama , Shinji Ina , Akane Takahama
IPC分类号： A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P37/08 , A61P43/00 , C07C225/20 , A61K31/135 , C07C43/20 , C07C211/00
CPC分类号： C07C225/20 , C07B2200/07 , C07C2601/08 , C07C2601/10 , C07C2602/42
摘要： (−)-3-[3-[(1R,2R,4S)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one, or its hydrate or solvate, or a pharmaceutical composition containing the same.
摘要翻译：（ - ） - 3- [3 - [（1R，2R，4S） - 双环[2.2.1]庚-2-基氧基] -4-甲氧基苯胺基] -2-甲基-2-环戊烯-1-酮，或其水合物或溶剂合物，或含有它们的药物组合物。

4. 发明授权

US07772258B2 Agent for treatment of allergic eye disease 失效
标题翻译：用于治疗过敏性眼病的药剂
公开(公告)号：US07772258B2
公开(公告)日：2010-08-10
申请号：US12189040
申请日：2008-08-08
申请人： Shinji Ina , Akane Takahama
发明人： Shinji Ina , Akane Takahama
IPC分类号： A61N43/40 , A61K31/135
CPC分类号： A61K31/122
摘要： An agent for the treatment of allergic eye disease containing a 3-anilino-2-cycloalkenone derivative having the formula (I): wherein R1 is an unsubstituted or substituted C1 to C8 alkyl group provided that an unsubstituted methyl group is excluded, a C3 to C7 cycloalkyl group, a C6 to C10 bicycloalkyl group or an indanyl group, etc., R2 is a C1 to C4 alkyl group, R3 is a hydrogen atom, a C1 to C5 alkyl group, a C3 to C7 cycloalkyl group, etc., R4 is a hydrogen atom, an unsubstituted or substituted C1 to C5 alkyl group, a halogen atom, etc., R5, R6, R7 and R8 are independently a hydrogen atom, a C1 to C5 alkyl group, etc., X is —(CR11R12)n— or NR13—, wherein n is 0 to 2, R11, R12 and R13 are independently a hydrogen atom, a C1 to C5 alkyl group, etc.
摘要翻译：用于治疗含有具有式（I）的3-苯胺基-2-环烯酮酮衍生物的过敏性眼病的药剂：其中R1是未取代或取代的C1至C8烷基，条件是排除未取代的甲基，C3至 C7环烷基，C6〜C10二环烷基或茚满基等，R2为C1〜C4烷基，R3为氢原子，C1〜C5烷基，C3〜C7环烷基等， R4是氢原子，未取代或取代的C1至C5烷基，卤素原子等，R5，R6，R7和R8独立地是氢原子，C1-C5烷基等，X是 - （ CR 11 R 12）n或NR 13 - ，其中n为0至2，R 11，R 12和R 13独立地为氢原子，C 1至C 5烷基等

5. 发明申请

US20140051876A1 METHOD FOR MANUFACTURING PHOSPHONOCROTONIC ACID DERIVATIVE 有权
标题翻译：制备磷酸酯衍生物的方法
公开(公告)号：US20140051876A1
公开(公告)日：2014-02-20
申请号：US14113498
申请日：2012-04-26
申请人： Shinji Ina , Takahiro Yamazaki , Junichi Sakata , Koji Ezaki , Katsuhiro Sakamoto
发明人： Shinji Ina , Takahiro Yamazaki , Junichi Sakata , Koji Ezaki , Katsuhiro Sakamoto
IPC分类号： C07C51/09 , C07C57/03 , C07F9/40
CPC分类号： C07C51/09 , A61K9/4858 , A61K9/4866 , A61K9/4875 , A61K31/167 , A61K31/202 , A61K33/16 , A61K35/742 , A61K35/744 , A61K45/06 , C07C51/353 , C07C57/03 , C07C67/343 , C07F9/4015 , A61K2300/00 , C07C69/587
摘要： Provided is a method of manufacturing a high quality phosphonocrotonic acid derivative.The present invention is a method of manufacturing a compound represented by the following Formula (3) by reacting a compound represented by the following Formula (1) with a compound represented by the following Formula (2), which comprises a treatment process using an acid or base.[in the formula, R1 represents a C1-6 linear or branched alkyl group that may be substituted by a C6-10 aryl group, a C2-6 linear or branched alkenyl group that may be substituted by a C6-10 aryl group, a C2-6 linear or branched alkynyl group that may be substituted by a C6-10 aryl group, or a C6-10 aryl group, R2 represents a hydrogen atom, or a C1-6 linear or branched alkyl group that may be substituted by a C6-10 aryl group, R3 represents a C1-6 linear or branched alkyl group, a C6-10 aryl group, or a halogen atom, and X represents a halogen atom, and multiple R1s may be the same or different].
摘要翻译：提供制造高品质膦酸巴豆酸衍生物的方法。本发明是通过使由下式（1）表示的化合物与下式（2）表示的化合物反应来制备由下式（3）表示的化合物的方法，该方法包括使用酸或基地。 [式中，R 1表示可被C 6-10芳基取代的C 1-6直链或支链烷基，可被C 6-10芳基取代的C 2-6直链或支链烯基，可被C 6-10芳基或C 6-10芳基取代的C 2-6直链或支链炔基，R 2表示氢原子，或可被C 1-6烷基取代的C 1-6直链或支链烷基 C6-10芳基，R3表示C1-6直链或支链烷基，C6-10芳基或卤素原子，X表示卤素原子，多个R1可以相同或不同]。

6. 发明授权

US06251897B1 6-phenyltetrahydro-1,3-oxazin-2-one derivative and pharmaceutical composition containing the same 失效
标题翻译： 6-苯基四氢-1,3-恶嗪-2-酮衍生物和含有它们的药物组合物
公开(公告)号：US06251897B1
公开(公告)日：2001-06-26
申请号：US09230869
申请日：1999-02-01
申请人： Shinji Ina , Kenjirou Yamana , Kyoji Noda
发明人： Shinji Ina , Kenjirou Yamana , Kyoji Noda
IPC分类号： A61K31535
CPC分类号： C07D413/04 , C07D265/10 , C07D413/06 , C07D413/12 , C07D417/04 , C07D417/12
摘要： A 6-phenyltetrahydro-1,3-oxazin-2-one derivative having the formula (I): wherein, R1 is an unsubstituted or substituted C1 to C8 alkyl group; an unsubstituted or substituted C3 to C7 cycloalkyl group;, etc., R2 is a C1 to C4 alkyl group, R3 is H; an unsubstituted or substituted C1 to C5 alkyl group; etc., R4 is H; an unsubstituted or substituted C1 to C6 alkyl group, and R5 and R6 are independently a hydrogen atom; an unsubstituted or substituted C1 to C5 alkyl group; etc. an optical isomer thereof, or a pharmacologically acceptable salt thereof, or a hydrate or a solvate thereof and pharmaceutical compositions containing the same, in particular a drug for the prevention or treatment of inflammatory diseases and a drug for asthma. The above 6-phenyltetrahydro-1,3-oxazin-2-one derivative has a strong type IV PDE inhibitory activity and has a bronchiodilator and antiinflammatory effects.
摘要翻译：具有式（I）的6-苯基四氢-1,3-恶嗪-2-酮衍生物：其中，R1是未取代或取代的C1至C8烷基; 未取代或取代的C 3〜C 7环烷基等; R 2为C 1〜C 4烷基，R 3为H; 未取代或取代的C1至C5烷基; 等等，R4是H; 未取代或取代的C1至C6烷基，R5和R6独立地为氢原子; 未取代或取代的C1至C5烷基; 其光学异构体或其药理学上可接受的盐，或其水合物或溶剂化物以及含有它们的药物组合物，特别是用于预防或治疗炎性疾病的药物和用于哮喘的药物。苯基四氢-1,3-恶嗪-2-酮衍生物具有强IV型PDE抑制活性，具有支气管扩张剂和抗炎作用。

7. 发明授权

US06235739B1 5-phenyl-3-pyridazinone derivatives and drug composition containing the same 失效
标题翻译： 5-苯基-3-哒嗪酮衍生物和含有它们的药物组合物
公开(公告)号：US06235739B1
公开(公告)日：2001-05-22
申请号：US09202317
申请日：1998-12-11
申请人： Shinji Ina , Kenjirou Yamana , Kyoji Noda
发明人： Shinji Ina , Kenjirou Yamana , Kyoji Noda
IPC分类号： A61K3150
CPC分类号： C07D237/04
摘要： A 5-phenyl-3-pyridazinone derivative having the formula (I) wherein R1 represents an unsubstituted or substituted C1 to C8 alkyl group, C3 to C7 cycloalkyl group, or indanyl group; R2 represents a C1 to C4 alkyl group; R3 represents a hydrogen atom or an unsubstituted or substituted C1 to C5 alkyl group; a C3 to C7 cycloalkyl group; or an aryl group which may contain a heteroatom; R4 and R5 independently represent a hydrogen atom, C1 to C6 alkyl group, an unsubstituted or substituted phenyl, or a monocyclic aryl group which may contain a heteroatom; a dotted line represents a single or double bond, provided that when the dotted line represents a single bond; R6 represents a hydrogen atom or C1 to C6 alkyl group.
摘要翻译：具有式（I）的5-苯基-3-哒嗪酮衍生物，其中R1表示未取代或取代的C1至C8烷基，C3至C7环烷基或茚满基; R2表示C1〜C4烷基; R3表示氢原子或未取代或取代的C1至C5烷基; C3至C7环烷基; 或可以含有杂原子的芳基; R4和R5独立地表示氢原子，C1-C6烷基，未取代或取代的苯基或可含有杂原子的单环芳基; 虚线表示单键或双键，条件是当虚线表示单键时; R6表示氢原子或C1〜C6烷基。

8. 发明授权

US09540301B2 Method for manufacturing phosphonocrotonic acid derivative 有权
标题翻译：膦酸巴豆酸衍生物的制备方法
公开(公告)号：US09540301B2
公开(公告)日：2017-01-10
申请号：US14113498
申请日：2012-04-26
申请人： Shinji Ina , Takahiro Yamazaki , Junichi Sakata , Koji Ezaki , Katsuhiro Sakamoto
发明人： Shinji Ina , Takahiro Yamazaki , Junichi Sakata , Koji Ezaki , Katsuhiro Sakamoto
IPC分类号： C07C51/09 , C07F9/40 , C07C57/03 , A61K31/167 , A61K31/202 , A61K33/16 , A61K35/742 , A61K35/744 , A61K45/06 , C07C67/343 , C07C51/353 , A61K9/48
CPC分类号： C07C51/09 , A61K9/4858 , A61K9/4866 , A61K9/4875 , A61K31/167 , A61K31/202 , A61K33/16 , A61K35/742 , A61K35/744 , A61K45/06 , C07C51/353 , C07C57/03 , C07C67/343 , C07F9/4015 , A61K2300/00 , C07C69/587
摘要： Provided is a method of manufacturing a high quality phosphonocrotonic acid derivative.The present invention is a method of manufacturing a compound represented by the following Formula (3) by reacting a compound represented by the following Formula (1) with a compound represented by the following Formula (2), which comprises a treatment process using an acid or base.[in the formula, R1 represents a C1-6 linear or branched alkyl group that may be substituted by a C6-10 aryl group, a C2-6 linear or branched alkenyl group that may be substituted by a C6-10 aryl group, a C2-6 linear or branched alkynyl group that may be substituted by a C6-10 aryl group, or a C6-10 aryl group, R2 represents a hydrogen atom, or a C1-6 linear or branched alkyl group that may be substituted by a C6-10 aryl group, R3 represents a C1-6 linear or branched alkyl group, a C6-10 aryl group, or a halogen atom, and X represents a halogen atom, and multiple R1s may be the same or different].
摘要翻译：提供制造高品质膦酸巴豆酸衍生物的方法。本发明是通过使由下式（1）表示的化合物与下式（2）表示的化合物反应来制备由下式（3）表示的化合物的方法，该方法包括使用酸或基地。 [式中，R 1表示可以被C 6-10芳基取代的C 1-6直链或支链烷基，可以被C 6-10芳基取代的C 2-6直链或支链烯基， 10芳基，可以被C 6-10芳基取代的C 2-6直链或支链炔基或C 6-10芳基，R 2表示氢原子或C 1-6直链或可被C 6-10芳基取代的支链烷基，R 3表示C 1-6直链或支链烷基，C 6-10芳基或卤素原子，X表示卤素原子，多个R 1可以相同或不同]。

9. 发明申请

US20100197698A1 5-PHENYL-3-PYRIDAZINONE DERIVATIVE 有权
标题翻译： 5-苯基-3-吡啶酮衍生物
公开(公告)号：US20100197698A1
公开(公告)日：2010-08-05
申请号：US12665492
申请日：2008-06-19
申请人： Noriaki Gomi , Shinji Ina , Kenjirou Yamana , Yoshio Kaneko
发明人： Noriaki Gomi , Shinji Ina , Kenjirou Yamana , Yoshio Kaneko
IPC分类号： A61K31/501 , C07D237/14 , A61K31/50 , C07D405/12 , A61P7/02
CPC分类号： C07D237/14 , C07D401/06 , C07D405/12 , C07D417/06
摘要： To find a compound having a tissue fibrinosis-inhibitory activity and a fibrinolytic activity, and to provide a novel compound that is useful for preventing and/or treating tissue fibrinosis diseases (pulmonary fibrosis, renal fibrosis etc.), diseases caused by pathological blood clots such as ischemic heart diseases (myocardial infarction, angina), intraatrial thrombus, pulmonary embolism, deep venous thrombosis, disseminated intravascular coagulation, ischemic cerebral diseases (cerebral infarction, cerebral bleeding) and arteriosclerosis and the like. To provide a pharmaceutical drug comprising a 5-phenyl-3-pyridazinone derivative represented by the following general formula (I): and an optical isomer thereof, or a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof, useful for preventing and/or treating disease conditions or symptoms mediated by plasminogen activator inhibitor-1.
摘要翻译：为了找到具有组织纤维蛋白沉积抑制活性和纤维蛋白溶解活性的化合物，并提供可用于预防和/或治疗组织纤维蛋白病（肺纤维化，肾纤维化等）的新型化合物，由病理性血块引起的疾病心肌梗塞，心绞痛，心内膜血栓，肺栓塞，深静脉血栓形成，弥散性血管内凝血，缺血性脑疾病（脑梗死，脑出血），动脉硬化等。提供一种药物，其含有下述通式（I）表示的5-苯基-3-哒嗪酮衍生物及其旋光异构体或其药学上可接受的盐或其水合物或溶剂合物，其用于预防和/ 或治疗由纤溶酶原激活物抑制剂-1介导的疾病状况或症状。

10. 发明授权

US08106053B2 5-phenyl-3-pyridazinone derivative 有权
标题翻译： 5-苯基-3-哒嗪酮衍生物
公开(公告)号：US08106053B2
公开(公告)日：2012-01-31
申请号：US12665492
申请日：2008-06-19
申请人： Noriaki Gomi , Shinji Ina , Kenjirou Yamana , Yoshio Kaneko
发明人： Noriaki Gomi , Shinji Ina , Kenjirou Yamana , Yoshio Kaneko
IPC分类号： A61K31/50 , A61K31/501 , C07D237/02
CPC分类号： C07D237/14 , C07D401/06 , C07D405/12 , C07D417/06
摘要： To find a compound having a tissue fibrinosis-inhibitory activity and a fibrinolytic activity, and to provide a novel compound that is useful for preventing and/or treating tissue fibrinosis diseases (pulmonary fibrosis, renal fibrosis etc.), diseases caused by pathological blood clots such as ischemic heart diseases (myocardial infarction, angina), intraatrial thrombus, pulmonary embolism, deep venous thrombosis, disseminated intravascular coagulation, ischemic cerebral diseases (cerebral infarction, cerebral bleeding) and arteriosclerosis and the like. To provide a pharmaceutical drug comprising a 5-phenyl-3-pyridazinone derivative represented by the following general formula (I): and an optical isomer thereof, or a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof, useful for preventing and/or treating disease conditions or symptoms mediated by plasminogen activator inhibitor-1.
摘要翻译：为了找到具有组织纤维蛋白沉积抑制活性和纤维蛋白溶解活性的化合物，并提供可用于预防和/或治疗组织纤维蛋白病（肺纤维化，肾纤维化等）的新型化合物，由病理性血块引起的疾病心肌梗塞，心绞痛，心内膜血栓，肺栓塞，深静脉血栓形成，弥散性血管内凝血，缺血性脑疾病（脑梗死，脑出血），动脉硬化等。提供一种药物，其含有下述通式（I）表示的5-苯基-3-哒嗪酮衍生物及其旋光异构体或其药学上可接受的盐或其水合物或溶剂合物，其用于预防和/ 或治疗由纤溶酶原激活物抑制剂-1介导的疾病状况或症状。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式